Back to search

Somatostatin Analogs in the Medical Management of Occult Bleeding of the Lower Digestive Tract

Data up to Jan 2025

Published2015
Citations7
References28

Total Citations Per Year

Abstract

References (28)

Our new president—Jon I. Isenberg, M.D

2001 • 647 citations

Angiodysplasia of the gastrointestinal tract.

1993 • 289 citations

A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia

2001 • 237 citations

Review article: gastrointestinal angiodysplasia - pathogenesis, diagnosis and management

2013 • 222 citations

Efficacy of Thalidomide for Refractory Gastrointestinal Bleeding From Vascular Malformation

2011 • 208 citations

Clinical applications of the argon plasma coagulator

2004 • 194 citations

American Gastroenterological Association medical position statement: Evaluation and management of occult and obscure gastrointestinal bleeding

2000 • 194 citations

The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract

1999 • 176 citations

Does Hormonal Therapy Have Any Benefit for Bleeding Angiodysplasia?

1992 • 151 citations

Long-Term Efficacy of Octreotide in the Prevention of Recurrent Bleeding from Gastrointestinal Angiodysplasia

2007 • 119 citations

Somatostatin Analogues in the Treatment of Recurrent Bleeding from Gastrointestinal Vascular Malformations: An Overview and Systematic Review of Prospective Observational Studies

2010 • 118 citations

Inhibition of Angiogenesis by Somatostatin and Somatostatin-like Compounds Is Structurally Dependent

1993 • 103 citations

Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine.

1993 • 87 citations

Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease

2000 • 84 citations

Long‐acting somatostatin analogues decrease blood transfusion requirements in patients with refractory gastrointestinal bleeding associated with angiodysplasia

2012 • 83 citations

Long‐acting octreotide as rescue therapy in chronic bleeding from gastrointestinal angiodysplasia

2007 • 72 citations

Somatostatin and the Gastrointestinal Tract

1998 • 67 citations

Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract

2001 • 64 citations

Thalidomide in refractory bleeding due to gastrointestinal angiodysplasias

2012 • 52 citations

Long acting release-octreotide as “rescue” therapy to control angiodysplasia bleeding: A retrospective study of 98 cases

2014 • 41 citations

Somatostatin for Upper Gastrointestinal Hemorrhage and Pancreatic Surgery

1999 • 40 citations

Somatostatin Therapy Ameliorates Chronic and Refractory Gastrointestinal Bleeding Caused by Diffuse Angiodysplasia in a Patient on Anticoagulation Therapy

2003 • 36 citations

The Effect of Octreotide on Gastroduodenal Blood Flow Measured by Laser Doppler Flowmetry in Rabbits and Man

1999 • 30 citations

Role of Photodynamic Therapy in the Management of Gastrointestinal Cancer

1999 • 26 citations

Octreotide Long-Acting Release is effective in preventing gastrointestinal bleeding due to angiodysplasias

2014 • 13 citations

Effects of a somatostatin analogue in occult gastrointestinal bleeding: a case report

2004 • 13 citations

Potential Indications for Octreotide in Gastroenterology: Summary of Workshop

1993 • 12 citations

The effect of octreotide on gastroduodenal blood flow measured by laser Doppler flowmetry in rabbits and man

1999 • 7 citations

Cited By (0)

Loading...